New research reveals that individuals who discontinue new slimming jabs like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who halt conventional lifestyle plans.
Research printed in a major health publication demonstrates that while overweight individuals frequently drop substantial amounts of their body weight while on the medication, the mass is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"People purchasing such treatments should be informed of the potential of rapid weight regain when the medication ends," warns researcher Dr. Susan Jebb.
Such speed of regain implies a return to starting weight in about 18 months.
Weighing Approaches
The study, which reviewed 37 of studies involving thousands of patients, contrasted the effects of these new drugs with older methods.
The team point out that people who shed pounds through dieting typically see a slower creep back—around 0.1 kg a month—post-intervention.
Explaining the Rapid Rebound
Experts suggest the mode of action of the injections accounts for the heightened weight return.
The injections copy a body's own chemical called GLP-1, which helps regulate appetite.
"Artificially providing the hormone levels far above than the body's typical production may cause the system to produce less of its endogenous hormone, and could diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication results in appetite is uncontrolled, making binge eating far more likely."
A Lifelong Condition?
Health authorities advise the jabs for individuals with obesity-related health risks, alongside recommended lifestyle changes.
A number of clinicians say that, considering the significant potential of relapse, the therapy might need to be ongoing.
This perspective is supported by pharmaceutical companies, who note that the findings "underscore the long-term character of excess weight," similar to managing conditions like diabetes.
Patient Testimonies
People who have come off the jabs explain a powerful resurgence of cravings.
"I experienced a trigger flipping and you become extremely hungry," said one woman.
This difficulty is worsened if users have not established sustainable lifestyle or habit modifications during therapy.
Widespread Interest
Survey data show that millions of people in the UK have used weight-loss jabs in the last 12 months, with interest being substantial.
- Adoption is greater among women than men.
- The middle-aged age group shows the highest usage rates.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, experts caution that while the jabs are effective agents for shedding pounds, they are not a standalone fix and long-term success relies on ongoing behavioural management.
